BENITIONSClinical Trial Intelligence

Brain Health in Midlife

該当なし 完了 NCT06640842

対象疾患Brain Health, Gestational Hypertension, Alzheimer Disease, Dementia
該当なし
スポンサーUniversity of Kansas Medical Center
ステータス完了
参加者数24 名
介入(薬剤)A combination of various tests and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy on brain health in midlife.
開始日2024年9月23日
完了日2025年6月13日
結果公開日2026年7月14日

概要

The purpose of this study is to learn if hypertensive disorders during pregnancy affects brain health in midlife.

Cardiometabolic Biomarkers - Glucose & Lipids

Baseline · mg/dL

Hypertensive Disorder of Pregnancy93.25 ± 15.71 mg/dL
Healthy Pregnancy94.50 ± 13.53 mg/dL
Hypertensive Disorder of Pregnancy170 ± 38.69 mg/dL
Healthy Pregnancy172.50 ± 28.27 mg/dL
Hypertensive Disorder of Pregnancy92.58 ± 32.81 mg/dL
Healthy Pregnancy132.42 ± 83.07 mg/dL

Cardiometabolic Biomarkers - Insulin

Baseline · uIU/mL

Hypertensive Disorder of Pregnancy7.44 ± 3.63 uIU/mL
Healthy Pregnancy14.13 ± 12.97 uIU/mL

Cardiometabolic Biomarkers - Hemoglobin A1C

Baseline · percentage of glycated hemoglobin

Hypertensive Disorder of Pregnancy5.72 ± 1.09 percentage of glycated hemoglobin
Healthy Pregnancy5.45 ± 0.34 percentage of glycated hemoglobin

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。